"Myeloid Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).
| Descriptor ID |
D022423
|
| MeSH Number(s) |
A11.627
|
| Concept/Terms |
Myeloid Cells- Myeloid Cells
- Cell, Myeloid
- Cells, Myeloid
- Myeloid Cell
|
Below are MeSH descriptors whose meaning is more general than "Myeloid Cells".
Below are MeSH descriptors whose meaning is more specific than "Myeloid Cells".
This graph shows the total number of publications written about "Myeloid Cells" by people in this website by year, and whether "Myeloid Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 1 | 1 | 2 |
| 2014 | 3 | 2 | 5 |
| 2015 | 3 | 1 | 4 |
| 2016 | 0 | 2 | 2 |
| 2017 | 4 | 8 | 12 |
| 2018 | 0 | 4 | 4 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 4 | 6 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 1 | 3 |
| 2025 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myeloid Cells" by people in Profiles.
-
Myeloid-specific CAMKK2 deficiency protects against diet-induced obesity and insulin resistance by rewiring metabolic gene expression and enhancing energy expenditure. Mol Metab. 2025 Nov; 101:102250.
-
TET2-mutant myeloid cells mitigate Alzheimer's disease progression via CNS infiltration and enhanced phagocytosis in mice. Cell Stem Cell. 2025 Aug 07; 32(8):1285-1298.e8.
-
Alternative splicing of KLF4 in myeloid cells: implications for cellular plasticity and trained immunity in cancer and inflammatory disease. Front Immunol. 2025; 16:1585528.
-
Histone acetylation modulators in breast cancer. Breast Cancer Res. 2025 Mar 31; 27(1):49.
-
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy. Cell Oncol (Dordr). 2025 Jun; 48(3):559-590.
-
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? Neuro Oncol. 2025 Jan 12; 27(1):33-49.
-
The Roles of Myeloid Cells in Breast Cancer Progression. Adv Exp Med Biol. 2025; 1464:397-412.
-
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions. Nat Cell Biol. 2024 Nov; 26(11):1971-1983.
-
Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling. Cell Rep Med. 2024 Aug 20; 5(8):101658.
-
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nat Commun. 2024 Jul 10; 15(1):5291.